Felix Kofi Erekuu Kuuseg, MD - Medicare Internal Medicine in Sumter, SC

Felix Kofi Erekuu Kuuseg, MD is a medicare enrolled "Internal Medicine" physician in Sumter, South Carolina. He graduated from medical school in 2001 and has 23 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Mcleod Loris Seacoast Hospital and his current practice location is 129 N Washington St, Sumter, South Carolina. You can reach out to his office (for appointments etc.) via phone at (803) 774-9680.

Felix Kofi Erekuu Kuuseg is licensed to practice in South Carolina (license number 31476) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1871732347.

Contact Information

Felix Kofi Erekuu Kuuseg, MD
129 N Washington St,
Sumter, SC 29150-4949
(803) 774-9680
(803) 774-5217



Physician's Profile

Full NameFelix Kofi Erekuu Kuuseg
GenderMale
SpecialityInternal Medicine
Experience23 Years
Location129 N Washington St, Sumter, South Carolina
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Felix Kofi Erekuu Kuuseg graduated from medical school in 2001
  NPI Data:
  • NPI Number: 1871732347
  • Provider Enumeration Date: 02/06/2009
  • Last Update Date: 01/07/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 6305997339
  • Enrollment ID: I20090702000019

Medical Identifiers

Medical identifiers for Felix Kofi Erekuu Kuuseg such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1871732347NPI-NPPES
314760MedicaidSC

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208000000XPediatrics 31476 (South Carolina)Secondary
207R00000XInternal Medicine 31476 (South Carolina)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Mcleod Loris HospitalLoris, SCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Mcleod Loris Seacoast Hospital9133394398104

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Felix Kofi Erekuu Kuuseg allows following entities to bill medicare on his behalf.
Entity Name24 On Physicians Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588613343
PECOS PAC ID: 5698688141
Enrollment ID: O20031111000018

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NameGeorgetown Memorial Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1982604021
PECOS PAC ID: 8224942123
Enrollment ID: O20031114000600

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NameWaccamaw Community Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972503910
PECOS PAC ID: 9133036932
Enrollment ID: O20031126000386

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NameGreenville Health System
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568532513
PECOS PAC ID: 8123938131
Enrollment ID: O20031212000723

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NamePrisma Health University Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568799955
PECOS PAC ID: 8325950983
Enrollment ID: O20040108000041

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NameSpartanburg Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699729939
PECOS PAC ID: 3072425297
Enrollment ID: O20040702000686

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NameApogee Medical Group South Carolina
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619028545
PECOS PAC ID: 8921193020
Enrollment ID: O20071004000474

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NamePelham Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619133568
PECOS PAC ID: 2365519097
Enrollment ID: O20080923000329

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NameMcleod Loris Seacoast Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1265708119
PECOS PAC ID: 9133394398
Enrollment ID: O20120710000230

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NameSound Physicians Of South Carolina, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922428358
PECOS PAC ID: 6800014762
Enrollment ID: O20140905002528

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Entity NameSoutheastern Hospitalist Services Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003280108
PECOS PAC ID: 3476855420
Enrollment ID: O20160125000378

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Felix Kofi Erekuu Kuuseg is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Felix Kofi Erekuu Kuuseg, MD
Po Box 743904,
Atlanta, GA 30374-3904

Ph: (803) 296-7320
Felix Kofi Erekuu Kuuseg, MD
129 N Washington St,
Sumter, SC 29150-4949

Ph: (803) 774-9680

News Archive

Research shows the effect of physical activity on bowel cancer cell growth

New research presented at The Physiological Society's Annual Conference Physiology 2021 shows that molecules released into the bloodstream during exercise (such as small proteins) can act directly on bowel cancer cells to slow down their growth.

New model helps predict outbreaks of zoonotic diseases

A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Sumter, SC

Fritz E Jean Gilles, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 129 N Washington St, Sumter, SC 29150
Phone: 803-774-9680    Fax: 803-774-5217
Dr. Thomas E Hawkey, D.O.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 12 Barnette Dr, Sumter, SC 29150
Phone: 803-773-5442    Fax: 803-778-2394
Dr. Joseph Cecil Williams, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 129 N Washington St, Sumter, SC 29150
Phone: 803-774-1788    Fax: 803-774-9113
Dr. John Julian Abbott, M.D.
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 129 N Washington St, Sumter, SC 29150
Phone: 803-774-5248    
Dr. Theophilus D Williams Iii, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 641 W Wesmark Blvd, Sumter, SC 29150
Phone: 803-905-6944    Fax: 803-469-3944
Harry A Jordan, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1295 Wilson Hall Rd, Sumter, SC 29150
Phone: 803-905-6800    Fax: 803-905-6810
Dr. Floyd L Angus, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 641 W Wesmark Blvd, Sumter, SC 29150
Phone: 803-905-6944    Fax: 803-469-3944

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.